CagriSemas REIMAGINE 13 program, presented at ADA 2026 and published simultaneously in The Lancet and The Lancet Diabetes & Endocrinology, showed superior HbA1c reduction and weight loss compared with semaglutide alone across multiple type 2 diabetes populations, including basal-insulin-treated patients in whom add-on CagriSema lowered HbA1c from 8.8% to 6.5% with up to 12% weight loss and no severe hypoglycemia
Available as topical creams, gels, and sprays
Our medical providers advise enhancing your IV experience with an add-on every time you drip
In Se supplemented group it increased after 1 and 3 months to 94.6 and 115 ng/mL, respectively)
Likewise, autoimmune conditions that affect the stomach lining, such as atrophic gastritis or pernicious anemia, directly impact intrinsic factora protein essential for B12 absorption
None of these represent indications for MediVeras compounded formulations, which are prepared by prescription for individualized patient use at the direction of a licensed prescriber